Literature DB >> 3436827

Cytogenetical observations in five human anaplastic thyroid carcinomas.

J Mark, C Ekedahl, R Dahlenfors, B Westermark.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3436827     DOI： 10.1111/j.1601-5223.1987.tb00281.x

Source DB:  PubMed          Journal:  Hereditas        ISSN： 0018-0661            Impact factor:   3.271


× No keyword cloud information.
  15 in total

1.  Origin and relationship between different cell types in malignant fibrous histiocytoma.

Authors:  M Genberg; J Mark; L Hakelius; J Ericsson; M Nistér
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

2.  Production of platelet-derived endothelial cell growth factor by normal and transformed human cells in culture.

Authors:  K Usuki; N E Heldin; K Miyazono; F Ishikawa; F Takaku; B Westermark; C H Heldin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  DNA copy number changes in thyroid carcinoma.

Authors:  S Hemmer; V M Wasenius; S Knuutila; K Franssila; H Joensuu
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

4.  Aberrant expression of receptors for platelet-derived growth factor in an anaplastic thyroid carcinoma cell line.

Authors:  N E Heldin; B Gustavsson; L Claesson-Welsh; A Hammacher; J Mark; C H Heldin; B Westermark
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Establishment of a human anaplastic thyroid cancer cell line secreting granulocyte colony-stimulating factor in response to cytokines.

Authors:  Y Oka; T Kobayashi; S Fujita; N Matsuura; S Okamoto; H Asakawa; A Murata; T Mori
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

Review 6.  Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.

Authors:  Robert C Smallridge; Laura A Marlow; John A Copland
Journal:  Endocr Relat Cancer       Date:  2008-11-05       Impact factor: 5.678

7.  Human recombinant anti-thyroperoxidase autoantibodies: in vitro cytotoxic activity on papillary thyroid cancer expressing TPO.

Authors:  S A Rebuffat; M Morin; B Nguyen; F Castex; B Robert; S Péraldi-Roux
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

8.  Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.

Authors:  M A Herrmann; I D Hay; D H Bartelt; S R Ritland; R J Dahl; C S Grant; R B Jenkins
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

9.  The Role of the PAX8/PPARgamma Fusion Oncogene in Thyroid Cancer.

Authors:  Kimberly A Placzkowski; Honey V Reddi; Stefan K G Grebe; Norman L Eberhardt; Bryan McIver
Journal:  PPAR Res       Date:  2008-10-29       Impact factor: 4.964

Review 10.  Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples.

Authors:  Franclim Ricardo Ribeiro; Ana Margarida Meireles; Ana Sofia Rocha; Manuel Rodrigues Teixeira
Journal:  BMC Cancer       Date:  2008-12-16       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.